UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6K
REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 AND 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 1998
NATIONAL HEALTHCARE MANUFACTURING CORPORATION
(Name of Registrant)
251 Saulteaux Crescent, Winnipeg, Manitoba Canada R3J 3C7
(Address of principal executive offices)
1. News Release: July 29, 1998
Material Change Report: Aug. 6, 1998
Indicate by check mark whether the Registrant files of will file annual
reports under cover of Form 20-F of Form 40-F.
Form 20-F x Form 40-F ___
Indicate by check mark whether the Registrant by furnishing the information
contained in this form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of
1934. Yes ___ No x
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1943 , the
registrant has duly cause this Form 6-K to be signed on its behalf by the
undersigned, thereunto duly authorized.
National Healthcare Manufacturing Corporation -- SEC No. 0-27998
(Registrant)
Date: August 6, 1998 By:/s/Seyed Torabian
---------------------------
M. Seyed Torabian,
Vice President/Director
NEWS RELEASE
FOR RELEASE JULY 29, 1998 AT 7:30 AM EDT
Contact:Allen & Caron Inc or Alex Tsakumis
Damon Wright (investors) Manager, Investor Relations
Denise Harrison (media) National Healthcare
(714) 957-8440 Manufacturing Corporation
(800) 883-8841
NATIONAL HEALTHCARE OFFICERS AND BOARD MEMBERS
ANNOUNCE INTENTION TO PURCHASE STOCK ON OPEN
MARKET FOR THEIR PRIVATE BROKERAGE ACCOUNTS
WINNIPEG, MANITOBA (July 29, 1998) . . . . National Healthcare
Manufacturing Corporation (Nasdaq: NHMCF) reported today that its President
& CEO Mac J. Shahsavar and other officers of the Company have announced
their intention to purchase for their private brokerage accounts up to one
million shares of National Healthcare Manufacturing on the open market
within the next twelve months. The Shahsavar family already owns 31.3
percent of National Healthcare prior to any further purchase of shares.
Shahsavar commented, "As we have moved the focus of our share trading
from Canada to the United States, the market has created a buying
opportunity for those of us who believe strongly in the Company's future,
and believe that the shares are undervalued.
"We are strongly focused on improving both our top and bottom line in
fiscal 1999," Shahsavar continued. "We expect to begin to see results from
our long-term approach towards sales and marketing and our strategic
investment in vertical integration, which includes our Hub & Spoke
logistics distribution business."
National Healthcare is committed to reducing healthcare costs by
providing efficient and cost effective alternatives to conventional
products and services to healthcare providers through the use of the
world's first and only automated robotic production facility capable of
assembling and packaging kits and trays for medical and surgical
procedures. Through its wholly-owned subsidiaries, National Healthcare
manufactures and distributes personal care, anti-microbial and cellulose
based paper products to healthcare and homecare institutions throughout
North America and Europe. National Healthcare Logistics (a subsidiary) is
revolutionizing conventional medical distribution with its state-of-the-art
Hub & Spoke logistics system.
The statements in this release that relate to future plans, events or
performance are forward-looking statements that involve risks and
uncertainties, including risks associated with uncertainties pertaining to
customer orders, development of markets for the Company's products and
services and other risks as identified in the Company's SEC filings.
Actual results, events and performance may differ materially. The Company
undertakes no obligation to publicly update these forward-looking
statements to reflect events or circumstances that occur after the date
hereof or to reflect the occurrence of unanticipated events.
August 6, 1998
B.C. Securities Commission
1100 - 865 Hornby Street
Vancouver, B.C.
V7Z 2H4
ATTN: Statutory Filing
RE: Material Change Report
Dear Sir/Madam,
Following please find National Healthcare Manufacturing Corporation's
Material Change Report/Form 27 dated August 6, 1998.
Should you have any questions or need more information, please contact me
at (604) 689-8581.
Sincerely,
/s/Seyed Torabian
Seyed Torabian, P.Eng.
Executive Vice-President
copy:Manitoba Securities Commission
U.S. Securities & Exchange Commission
NASDAQ
Standard & Poor's
Maitland & Company
FORM 27
SECURITIES ACT (BRITISH COLUMBIA)
MATERIAL CHANGE REPORT UNDER SECTION 67 (1) (B) OF THE ACT
Item 1. Reporting Issuer
National Healthcare Manufacturing Corporation
251 Saulteaux Crescent
Winnipeg, Manitoba
R3J 3C7
Item 2. Date of Material Change
June 8, 1998
Item 3. Press Release
News release and notice of dissemination were issued to the
Vancouver Stock Exchange on June 8, 1998 and disseminated via
Canadian Corporate News, Market News Publishing and Vancouver
Stockwatch.
Item 4. Summary of Material Change
The Issuer announces that it has appointed Allen & Caron Inc. as
its corporate investor and financial relations firm.
Item 5. Full Description of Material Change
Please refer to the attached News Release(s) of the Issuer dated
June 8, 1998.
Item 6. Reliance in Section 67(2) of the Act
If the report is being filed on a confidential basis in reliance
on Section 67(2) of the Act, state the reason for such reliance.
N/A
Item 7. Omitted Information
N/A
Item 8. Senior Officer
M. Seyed Torabian, the Executive Vice-President and Director of
the Issuer, is knowledgeable about the material change and this
report and may be contacted at (604) 689 - 8581 for further
information.
Item 9. Statement of Senior Officer
The foregoing accurately discloses the material change referred
to herein.
Dated at Vancouver, British Columbia, this 6th day of August, 1998.
National Healthcare Manufacturing Corporation
Per: /s/Seyed Torabian"
Seyed Torabian, P.Eng.
Executive Vice-President/Director
FOR IMMEDIATE RELEASE
Contact: Allen & Caron Inc or Alex Tsakumis
Damon Wright (investors) Manager, Investor Relations
Denise Harrison (media) National Healthcare
(714) 957-8440 Manufacturing Corporation
(800) 883-8841
NATIONAL HEALTHCARE MANUFACTURING CORP SELECTS
ALLEN & CARON INC FOR INVESTOR RELATIONS,
CORPORATE COMMUNICATIONS
WINNIPEG, MB, CANADA (June 8, 1998) . . .National Healthcare Manufacturing
Corporation (Nasdaq:NHMCF / VSE:NHM) today announced the appointment of
Allen & Caron, Inc as its corporate, investor, and financial relations
firm. Allen & Caron Inc. has been retained for a 12 month period at a cost
of US$7000 per month payable in cash.
National Healthcare Manufacturing President and CEO Mac J. Shahsavar
commented, "During the last year, we have been aggressively expanding our
product lines and distribution capabilities. As we continue to execute our
strategic growth plan, we will call on the professional experience of Allen
& Caron to assist us in properly positioning the Company in the investment
community. In addition, their experience will be instrumental in
introducing the Company to institutional investors, analysts and retail
investment banks, as well as to the business, financial, manufacturing and
packaging trade media."
Allen & Caron President Joseph Allen said, "The success of the Company's
proprietary automated robotic production facility and hub-and-spoke
distribution system, coupled with recent synergistic acquisitions, is
reflected in its rapid revenue growth. Management's business plan fits
well with our expanding list of emerging growth companies. We look forward
to working closely with the senior management of National Healthcare,"
Allen continued, "to ensure that the Company's corporate and investor
communications needs are effectively met with a full-range of professional
services."
For a complete corporate package, please visit our website at
http://www.nationalhealthcare.com or contact us at 1-800-883-8841.
On Behalf of the Board,
/s/Seyed Torabian
Seyed M. Torabian, P.Eng.
Executive Vice President
Neither NASDAQ nor the VSE have reviewed or accept responsibility for the
accuracy of this release.